Navigation Links
ImmusanT Initiates Study at Joslin Diabetes Center to Investigate Relationship Between Celiac Disease and Type 1 Diabetes
Date:8/6/2013

CAMBRIDGE, Mass., Aug. 6, 2013 /PRNewswire/ -- ImmusanT today announced that it has initiated a clinical research study to explore the immunologic relationship between celiac disease and Type 1 diabetes (T1D) and to further understand the underlying cause of T1D. The research will focus on characterizing immune responses in patients affected by both T1D and celiac disease. The study will be performed by the Joslin Diabetes Center.

It is estimated that celiac disease affects about one in 100 Americans, but in people with T1D about one in 10 are affected by the disease. Celiac disease is caused by an immune response to dietary gluten, but the trigger for the immune response causing T1D is not as clear. Studies suggest that genes putting people at risk of T1D and celiac disease are the same, and shared by several other common autoimmune diseases. Further research into whether the immune response causing celiac disease is related to the autoimmune response causing T1D may reveal new information about autoimmune disease in general.

The study with Joslin will assess patients with celiac disease only and patients who have both celiac disease and T1D. The goal of the study is to compare biomarker response in both sets of patients, which may elucidate drivers of T1D. In the long-term, this study could provide insights into potential treatments for T1D.

"Type 1 diabetes and celiac disease appear to be closely related, so it is natural that the next disease that ImmusanT would examine is T1D," noted Bob Anderson, Chief Scientific Officer of ImmusanT and the inventor of Nexvax2®. "By better understanding the mechanisms that are common to T1D and celiac disease, we may be able to leverage our expertise gained from developing Nexvax2 to identify a way to halt or prevent the autoimmune response in patients with Type 1 diabetes."

"ImmusanT pioneered the development of the only antigen-s
'/>"/>

SOURCE ImmusanT, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
2. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
3. Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain
4. Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
5. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
6. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
7. Advanced Cell Diagnostics Initiates Agreement to Study Biomarkers for Cancer Immunotherapy
8. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
9. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
10. Medbox, Inc. Initiates "Responsible Consumption" Campaign for Marijuana in Recreational States
11. Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... TORONTO , Sept. 22, 2014 ... announced that it has entered into a collaboration ... UHN,s Centre for Molecular Design and Preformulations (CMDP) ... The goal of the project is to increase ... proprietary buccal insulin spray product, thereby reducing the ...
(Date:9/22/2014)... 2014 METTLER TOLEDO is pleased ... measuring device CNS110 ScanTape™ . Replacing a ... offering greater ease and accuracy for transport and ... significantly enhance productivity—an important benefit for load planning ... equals profits. , Usable at any point ...
(Date:9/21/2014)... Chemical Sciences play a significant ... clean air and safe water, healthy food, and ... environmentalists, food scientists, educators, and scientists have a ... field of Chemistry for the national development, and ... of the fastest emerging Sciences, accelerating with a ...
(Date:9/19/2014)... is rarely simple. From crop yields to disease risks, ... those considered "complex traits." Just as for heightthe textbook ... particular human disease are shaped by multiple genetic and ... involved. To track down such genes, geneticists typically mate ... large mouse and a small mouseand then study their ...
Breaking Biology Technology:Generex Collaborates with University Health Network for Buccal Insulin Project 2Generex Collaborates with University Health Network for Buccal Insulin Project 3Generex Collaborates with University Health Network for Buccal Insulin Project 4ScanTape™ Handheld Dimensioner Increases Processing Volume 2Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3Want to link genes to complex traits? Start with more diversity 2
... Company Selected to Participate in Gastroenterology Panel Discussion, ... ) announced today that Chief Executive Officer Elkan R. ... 2007 RBC Capital Markets Healthcare Conference taking place December ... Times Square in New York, New York.,The panel is ...
... Dec. 10 Lexicon,Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... participate in the RBC Capital Markets,Healthcare Conference panel Going ... Westin Times Square Hotel in New York, New York ... A live audio webcast of the panel presentation ...
... Harrisburg Regional Education Consortium Promoting Advanced Technology,Industries ... High school and,college students from the Harrisburg ... and curriculum through a special collaboration,between several ... BioTech Day 2007, hosted by the Harrisburg ...
Cached Biology Technology:Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference 2Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference 2Capital Area Biotechnology Partnership Receives $160,000 State Investment 2
(Date:9/21/2014)... the University of California, San Diego, have developed a ... control the activity of genes based on sequences of ... its application to human embryonic cells in a paper ... , "All of our cells have the same blueprint, ... John Whitaker, lead author of the report. "Skin cells ...
(Date:9/21/2014)... as mussels and barnacles secrete very sticky proteins that ... underwater. Inspired by these natural adhesives, a team of ... used to repair ships or help heal wounds and ... the MIT researchers engineered bacteria to produce a hybrid ... as a bacterial protein found in biofilms slimy ...
(Date:9/19/2014)... by researchers from several Harvard University labs in ... and aspiring researchers with the intellectual raw materials ... from soft, flexible materials. , With the advent ... advances in manufacturing technology, soft robotics is emerging ... from conventional rigid robot design, but working with ...
Breaking Biology News(10 mins):Program predicts placement of chemical tags that control gene activity 2Engineered proteins stick like glue -- even in water 2Engineered proteins stick like glue -- even in water 3Soft robotics 'toolkit' features everything a robot-maker needs 2
... 12, 2009)The Society of Interventional Radiology hailed the ... in support of clinical patient management by vascular ... the critical contribution these minimally invasive specialists bring ... of ACR,s Resolution 22 is a continued endorsement ...
... This release is available in German . ... because of the limited amount of fossil fuels available, ... and other plant waste, are becoming the focus of ... the conversion of biomass into bio-oil, a highly promising ...
... Nlets Network and Hosting Services Enhances Law Enforcement ... Inc. (OTC Bulletin Board: BKYI), a leader in ... today announced a strategic partnership with Nlets. Nlets ... data communications network for the exchange of law ...
Cached Biology News:Interventional radiology: From sidelines to mainstream for patients 2Biomass as a source of raw materials 2BIO-key(R) Enters Strategic Partnership With Nlets 2BIO-key(R) Enters Strategic Partnership With Nlets 3
... dispenser combining the most versatile features for bulk ... existing Multidrop dispensers. , ,It is designed ... nl up to 2500 l with excellent precision ... for multiple plate formats (96, 384, 1536) including ...
... Multidrop Combi is a new generation bulk ... flexibility and simplicity for pharmaceutical and biotech ... reliable Multidrop range, Multidrop Combi has been ... volumes of 0.5-2500 l and multiple plate ...
Multidrop DW is a high-speed automated dispenser for Deep Well plates, 1.1 ml test tubes and 96-well plates. Designed for accuracy and precision, the Multidrop DW dispenses up to eight different reag...
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
Biology Products: